RxDoctor Payments Data

Amy Albrecht

Family · Huron, SDNPI 1386015535

Payments from drug & device makers

$1,541in general payments, 2019–2025

Across 117 payments — averaging $13.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$244
  • Lilly USA, LLC$210
  • Novo Nordisk$200
  • Pfizer$139
  • Grifols USA, LLC$126
  • Novartis$101
  • plus $521 from 13 others

What the payments were for

  • Food & beverage$1,541100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,541 in reported general payments places this provider in the 80th percentile of 588 family providers in South Dakota.

See all family providers in South Dakota

Medicare billing

Part B allowed, 2024
$110,139
Medicare patients
126
Services billed
3,850

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$27,139
MounjaroTirzepatide22$21,993
OzempicSemaglutide20$18,555
JanuviaSitagliptin Phosphate31$17,758
JardianceEmpagliflozin20$15,588
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,947
Spiriva RespimatTiotropium Bromide19$9,763
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,342
LinzessLinaclotide15$8,393
Breo ElliptaFluticasone/Vilanterol21$8,062
Combivent RespimatIpratropium/Albuterol Sulfate11$5,330
MyrbetriqMirabegron13$5,299
SymbicortBudesonide/Formoterol Fumarate16$3,695
Ventolin HfaAlbuterol Sulfate41$2,332
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$1,879

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat$73$30,68150 claims
PfizerEliquis$139$27,13928 claims
Lilly USA, LLCMounjaro$210$21,99322 claims
Novo NordiskOzempic$200$18,55520 claims
MerckJanuvia$63$17,75831 claims
AstraZenecaBreztri Aerosphere, Symbicort$12$13,03731 claims
AbbVieLinzess, Synthroid$29$9,05735 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 588 family providers in South Dakota.

Other family in Huron

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →